|
Bob joined ARCH at its founding and has played a significant role in the early sourcing, financing and development of more than thirty companies. He is a director of Adolor, Elixir, Ensemble Discovery, NeurogesX, and Ikaria, among others. Bob also serves on the board of Fred Hutchinson Cancer Research Institute. Bob holds an MBA from the University of Chicago and a BS in both Economics and Biology from the University of Puget Sound. | 